Combination therapy for HIV: the effect on inpatient activity, morbidity and mortality of a cohort of patients

Brettle, Ray P.; Wilson, Alan; Povey, Sarah; Morris, Sheila; Morgan, Rhoda; Leen, Clifford L. S.; Hutchinson, Sharon; Lewis, Steff; Gore, Sheila; Brettle, R P; Wilson, A; Povey, S; Morris, S; Morgan, R; Leen, C L; Hutchinson, S; Lewis, S; Gore, S
February 1998
International Journal of STD & AIDS;Feb1998, Vol. 9 Issue 2, p80
Academic Journal
journal article
We set out to quantify the changes in HIV-related morbidity and mortality associated with the clinical use of antiretroviral therapy via prospectively collected patient-related events (admissions, bed days, deaths, WHO stage 3 and 4 events and drug costs) on all HIV patients known to the Regional Infectious Disease Unit (RIDU) from 1 January 1987 to 31 December 1996. The introduction of zidovudine monotherapy in 1987 for those with AIDS was associated with a subsequent decline of inpatient activity for 2 years: in 1989 there was a 23% reduction in bed days but only a 6% reduction in admissions. A further dramatic decline of patient-related events in those with AIDS was noted during 1996 following the introduction of combination therapy, a 39% reduction in admissions, 44% reduction in bed days, 54% reduction in stage 4 events, 33% reduction in WHO stage 3 events and 40% reduction in the death rate. Reductions were also observed for patients without AIDS including a 42% reduction in the rate of patients developing AIDS. Similar reductions were noted when the patients were classified by immunological instead of clinical status although data for 1997 suggest an increase in patient-related activity for those with CD4 counts >200 cells/microl possibly as a result of low levels of anti-HIV therapy. The introduction of combination therapy for HIV has to date led to a minimum saving of one inpatient bed per 100 patient years which helped defray the cost of combination therapy. Although we cannot imply causality from an observational study, dramatic reductions in patient-related activity were associated with the introduction of combination therapy into clinical practice. The ultimate extent and duration of this effect cannot as yet be predicted and caution is required since similar reductions were noted with zidovudine therapy which were unfortunately time limited.


Related Articles

  • Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans. Crothers, Kristina; Goulet, Joseph L.; Rodriguez-Barradas, Maria C.; Gilbert, Cynthia L.; Butt, Adeel A.; Braithwaite, R. Scott; Peck, Robin; Justice, Amy C.; Gibert, Cynthia L // JGIM: Journal of General Internal Medicine;Jun2007, Vol. 22 Issue 6, p749 

    Background: Cigarette smoking is an important risk factor for morbidity and mortality in HIV-positive patients on combination antiretroviral therapy.Objective: To determine whether awareness of smoking differs between HIV and non-HIV providers, and to identify factors...

  • Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study. Worm, Signe Westring; Sabin, Caroline; Weber, Rainer; Reiss, Peter; El-Sadr, Wafaa; Dabis, Francois; De Wit, Stephane; Law, Matthew; D'Arminio Monforte, Antonella; Friis-Møller, Nina; Kirk, Ole; Fontas, Eric; Weller, Ian; Phillips, Andrew; Lundgren, Jens // Journal of Infectious Diseases;2/1/2010, Vol. 201 Issue 3, p318 

    Background. The risk of myocardial infarction (MI) in patients with human immunodeficiency virus (HIV) infection has been assessed in 13 anti-HIV drugs in the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Methods. Poisson regression models were adjusted for cardiovascular...

  • Intrapartum HIV Enfeksiyonunda Zidovudin, Lamivudin ve Nevirapinden OluÅŸan Postpartum Antiretroviral Profilaksisi. Kara, Ahu; Bayram, Nuri; Devrim, İlker // Journal of Pediatric Infection / Cocuk Enfeksiyon Dergisi;Dec2014, Vol. 8 Issue 4, preceding p148 

    No abstract available.

  • The Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN Study). Claudia Vellozzi; John T. Brooks; Timothy J. Bush; Lois J. Conley; Keith Henry; Charles C. J. Carpenter; E. Turner Overton; John Hammer; Kathy Wood; Scott D. Holmberg; the SUN Study Investigators // American Journal of Epidemiology;Mar2009, Vol. 169 Issue 5, p642 

    Treatment of human immunodeficiency virus (HIV) infection with highly active combination antiretroviral therapy has increased survival and shifted the spectrum of HIV-associated morbidity and mortality from opportunistic infections toward a variety of other medical conditions. The prospective...

  • Infant HIV-1 Vaccines. Fouda, Genevieve G.; Cunningham, Coleen K.; Permar, Sallie R. // JAMA: Journal of the American Medical Association;4/21/2015, Vol. 313 Issue 15, p1513 

    The article discusses a program by the World Health Organization (WHO) to prevent mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) through maternal antiretroviral therapy (ART). Topics include the program's poor performance record; reasons that maternal ART can be...

  • Antiretroviral therapy initiation in an Australian cohort: implications for increased use of antiretroviral therapy. Stratov, I.; Kent, S. // European Journal of Clinical Microbiology & Infectious Diseases;Feb2015, Vol. 34 Issue 2, p253 

    Human immunodeficiency virus (HIV) management is entering a 'universal test and treat' phase, although the benefits from this approach in developed world scenarios are uncertain. We analyzed 79 combination anti-retroviral therapy (cART)-naïve HIV-positive individuals who were intensively...

  • The effect of divalproex sodium on viral load: a retrospective review of HIV-positive patients with manic syndromes. Maggi, Julie D.; Halman, Mark H.; Maggi, J D; Halman, M H // Canadian Journal of Psychiatry;May2001, Vol. 46 Issue 4, p359 

    Objective: In vitro studies report that valproic acid causes an increase in HIV-1 replication. This retrospective study examines a sample of patients with HIV disease and behavioural disturbances, for which the treatment of choice is divalproex sodium (DVP), to determine whether DVP...

  • The Evolution of Coreceptor Tropism in HIV-infected Patients Interrupting Suppressive Antiretroviral Therapy. Waters, Laura J.; Scourfield, Andrew T.; Marcano, Marie; Gazzard, Brian G.; Bower, Mark; Nelson, Mark; Stebbing, Justin // Clinical Infectious Diseases;3/1/2011, Vol. 52 Issue 5, p671 

    CCR5 antagonists may provide a well-tolerated switch option for patients experiencing tolerability or toxicity of their antiretroviral regimen. We analyzed stored samples from patients undergoing planned treatment interruptions for reasons other than virological failure, in order to analyze...

  • No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial Grijsen, Marlous L.; Steingrover, Radjin; Wit, Ferdinand W. N. M.; Jurriaans, Suzanne; Verbon, Annelies; Brinkman, Kees; van der Ende, Marchina E.; Soetekouw, Robin; de Wolf, Frank; Lange, Joep M. A.; Schuitemaker, Hanneke; Prins, Jan M. // PLoS Clinical Trials;Mar2012, Vol. 7 Issue 3, p1 

    In a three-arm randomized trial conducted among adult patients in HIV treatment centers in The Netherlands, Marlous Grijsen and colleagues examine the effects of temporary combination antiretroviral therapy during primary HIV infection.

  • Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients. Ingle, Suzanne M.; May, Margaret T.; Gill, M. John; Mugavero, Michael J.; Lewden, Charlotte; Abgrall, Sophie; Fätkenheuer, Gerd; Reiss, Peter; Saag, Michael S.; Manzardo, Christian; Grabar, Sophie; Bruyand, Mathias; Moore, David; Mocroft, Amanda; Sterling, Timothy R.; D'Arminio Monforte, Antonella; Hernando, Victoria; Teira, Ramon; Guest, Jodie; Cavassini, Matthias // Clinical Infectious Diseases;Jul2014, Vol. 59 Issue 2, p287 

    Among HIV-infected patients who initiated antiretroviral therapy (ART), patterns of cause-specific death varied by ART duration and were strongly related to age, sex, and transmission risk group. Deaths from non-AIDS malignancies were much more frequent than those from cardiovascular...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics